NICHD - News Releases

All News releases related to International Health

Your search for: All Related News Releases All Years returned the following 27 results:

10/19/09		NIH Newborn Screening Research Program Named In Memory of Hunter Kelly
The National Institutes of Health today announced the establishment of a research program to enhance newborn screening, in memory of the son of National Football League Pro Football Hall of Fame quarterback Jim Kelly.

06/11/09		Item of Interest: Public Comment on the DRAFT Endocrinology, Nutrition, and Growth (ENG) Branch Report to Council
A draft of the ENG Branch Report to the NACHHD Council is now available.

03/05/08		NIH Receives Gates Foundation Grant to Investigate Role of Iron Supplements in Malaria
Do iron supplements worsen the course of malaria? Researchers aren’t sure, and the uncertainty has jeopardized efforts to treat the debilitating effects of iron deficiency in parts of the world where malaria and other infectious diseases are common.

02/28/08		Tobacco Use, Secondhand Smoke Exposure during Pregnancy, May Threaten Health of Women and Children in Developing Nations
Findings from a National Institutes of Health (NIH) study indicate that rates of tobacco use during pregnancy, as well as exposure of pregnant women and their young children to secondhand smoke, are significant threats to health in several low and middle-income countries.

02/06/08		Item of Interest: Extended Nevirapine Regimens Reduce HIV Transmission and Death in Breastfed Infants of HIV-infected Mothers
An extended course of the antiretroviral drug nevirapine (NVP) helps the breastfeeding babies of HIV-infected mothers remain HIV-negative and live longer, according to several new studies presented at the 15th Conference on Retroviruses and Opportunistic Infections held in Boston from February 3–6.

02/06/08		Item of Interest: The Post-Exposure Prophylaxis of Infant (PEPI)-Malawi Study Sponsored by NICHD and CDC
Questions and Answers

01/10/07		Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive Regimen
A woman's response to HIV treatment with drug combinations that contain nevirapine is improved if at least six months have passed after she received the drug as a single dose during labor to prevent passing HIV on to her child. (The response to treatment is measured by the reduction of HIV in the blood.)

12/18/06		Malaria Vaccine Prompts Victims' Immune System to Eliminate Parasite From Mosquitoes
Researchers at the National Institutes of Health have developed an experimental vaccine that could, theoretically, eliminate malaria from entire geographic regions, by eradicating the malaria parasite from an area’s mosquitoes.

12/07/06		Hormonal Contraception Does Not Appear To Increase HIV Risk
Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, report the authors of a large study commissioned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

10/05/06		Drug Prevents PostPartum Hemorrhage in Resource Poor Settings Advance Has Potential to Save Thousands of Lives
The drug misoprostol provides a safe, convenient, and inexpensive means to prevent postpartum hemorrhage, a major killer of women in developing countries. The study was conducted by researchers from the University of Missouri, India’s Jawaharlal Nehru Medical College, and the National Institutes of Health.

09/19/05		Researchers Discover How Malaria Parasite Disperses From Red Blood Cells
Researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development have determined the sequence in which the malaria parasite disperses from the red blood cells it infects. The National Institute of Child Health and Human Development is one of the National Institutes of Health.

04/07/05		NICHD Launches Project to Treat Infant Asphyxia In Lower Income Countries
Scientists in a federally sponsored global research network will undertake a new project that will train midwives and traditional birth attendants in resource poor countries on how to treat newborn asphyxia, a major cause of infant death. The treatment, developed in the United States, is the standard of care provided to infants born in this country.

08/23/04		Depo Provera Appears to Increase Risk for Chlamydial and Gonococcal Infections
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive, according to a study jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health and the U.S. Agency for International Development's Office of Population and Reproductive Health.

07/09/04		Thai Study Shows That Inexpensive Treatment Reduces Risk Of Mother To Child HIV Transmission
A single dose of the drug nevirapine given at the beginning of labor, when combined with a short course of the anti-HIV drug AZT (zidovudine), dramatically reduces a woman's chances of passing HIV on to her child, according to a study of Thai women funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

06/30/04		Multivitamins During Pregnancy and After Birth Delay Progression of HIV In Women
Multivitamin supplements containing high doses of the vitamin B complex, as well as vitamins C and E, given to HIV-infected women during pregnancy and for more than 5 years after they gave birth reduced the symptoms of AIDS, according to a study of Tanzanian women supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the John E. Fogarty International Center (FIC) for Advanced Study in the Health Sciences, both of the National Institutes of Health. The supplements also bolstered counts of disease-fighting immune cells, and modestly lowered HIV levels in the blood.

Page 1 2 >

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.